Direct-from-Lysate SNP Genotyping in Research Applications

Comparison of traditional DNA purification workflow and direct-from-lysate workflow using DNA Extract All Reagents for SNP genotyping prior to qPCR.
Direct-from-lysate workflow enabled by DNA Extract All Reagents compared to traditional DNA purification for SNP genotyping applications.

Can You Perform SNP Genotyping Without DNA Purification?

The short answer: In many research workflows, direct-from-lysate SNP genotyping can be performed without traditional DNA purification—when appropriate chemistries and verification procedures are used.

Direct-from-lysate SNP genotyping enables allele discrimination directly from crude blood or buccal lysates. Advances in inhibitor-tolerant master mixes and optimized lysis reagents now allow reliable qPCR performance without column- or bead-based purification steps.

For laboratories running SNP panels, this approach may reduce hands-on time and consumable use while maintaining concordant genotype calls.


Why DNA Purification Became Standard

Biological samples such as whole blood contain PCR inhibitors, including:

  • Hemoglobin
  • Anticoagulants, such as Heparin
  • Lipids
  • Salts
  • Cellular debris

Historically, purification was required to remove these inhibitors through binding, washing, and elution steps. While effective, purification workflows introduce additional processing, reagents, plastic consumables, and handling complexity. For targeted SNP genotyping panels—particularly when only a limited number of loci are interrogated—the benefits of purification should be evaluated against workflow needs and downstream requirements


What Has Changed: Inhibitor-Tolerant PCR Chemistry

Recent advances in enzymology and PCR formulation have improved tolerance to common blood-derived inhibitors.

When combined with optimized lysis reagents such as the DNA Extract All Reagents Kit, inhibitor-tolerant chemistries enable direct-from-lysate SNP genotyping without traditional purification steps.

Under evaluated research conditions, these systems have demonstrated:

  • Tolerance to common inhibitors from blood and buccal sample matrices
  • Reliable amplification performance
  • Concordant allele discrimination compared to purified DNA

Direct-to-PCR reagents enable simplified workflows by omitting column- and bead-based extraction without sacrificing performance.


Technical Evaluation: Concordant Results with Crude Lysates

A technical evaluation described in Fast, simple SNP genotyping with multiplex qPCR assessed SNP genotyping performance using crude lysates compared to purified DNA across whole blood and buccal swab samples.

Across multiple pharmacogenomics-relevant targets, the evaluation reported:

  • Complete concordance within the evaluated sample set
  • Concordant genotype calls in both singleplex and multiplex assay formats
  • Consistent performance under defined experimental conditions

In this evaluation, crude lysates were prepared using DNA Extract All Reagents and amplified using TaqPath™ ProAmp™ Master Mix, in combination with TaqMan™ SNP Genotyping Assays.

These findings indicate that, under evaluated research conditions, direct-from-lysate SNP genotyping workflows can generate genotype calls consistent with purified DNA workflows.


Peer-Reviewed Publication: Genetic Risk Score Determination from Blood Lysates

In a 2024 peer-reviewed publication in the Journal of Translational Medicine, Locke et al. evaluated a 10-SNP genetic risk score using crude blood lysates without DNA purification.

The authors applied the TaqMan Sample-to-SNP workflow, which included crude lysate preparation using DNA Extract All Reagents and amplification with TaqPath™ ProAmp™ Master Mix in combination with TaqMan™ SNP Genotyping Assays.

Reported findings included:

  • High completion rates for genotype calls
  • Strong agreement with purified DNA–based workflows
  • Estimated genotype error rates comparable to purified DNA workflows

The authors also described lower per-sample reagent costs for crude lysate preparation compared to commonly used sample preparation methods.

These findings suggest that, for defined research applications involving limited SNP panels, direct-from-lysate workflows may be suitable when appropriate verification procedures are applied.


Workflow Comparison: Purification vs Crude Lysate

The comparison below summarizes workflow characteristics described in the technical note Fast, simple SNP genotyping with multiplex qPCR, which evaluated sample preparation steps and hands-on time for DNA purification and crude lysate preparation under research conditions.

Comparison of hands-on time, turnaround time and consumables used for sample extraction and crude lysate preparation. Estimated times and consumables are per sample and depend on the number of samples processed.

FeaturePurified DNA WorkflowCrude Lysate Workflow (DNA Extract All Reagents)
Processing steps≥18 steps3 steps
Reagents≥5 reagents2 reagents
Tubes / consumablesMultiple tubes or plates1 tube
Hands-on time~20–45 minutes≤5 minutes

For laboratories using targeted SNP genotyping panels, reducing processing steps and consumable use may simplify sample preparation while maintaining assay performance.


Experimental Considerations for Direct-from-Lysate SNP Genotyping

When implementing direct-from-lysate SNP genotyping in research applications:

  • Use inhibitor-tolerant master mixes designed for crude lysates
  • Follow recommended lysate input volumes
  • Verify performance using representative sample types
  • Confirm genotype clustering and allele discrimination metrics
  • Assess compatibility with multiplex assay formats if applicable

An integrated research workflow may include:

QuantStudio™ Real-Time PCR Systems for qPCR analysis


When Should You Still Purify DNA?

DNA purification may remain appropriate when:

  • DNA is required for sequencing or NGS workflows
  • Long-term storage or archiving is needed
  • Downstream applications require highly purified nucleic acids
  • Higher DNA concentration is required

Workflow suitability should be determined based on application requirements.


Frequently Asked Questions

1. How does direct-from-lysate SNP genotyping overcome PCR inhibitors?

Direct-from-lysate workflows rely on optimized lysis reagents and inhibitor-tolerant qPCR chemistries to maintain assay performance.

2. Is genotype clustering comparable to purified DNA workflows?

Technical evaluations and peer-reviewed publications have reported allele discrimination patterns consistent with purified DNA workflows when validated protocols were followed.

3. Is this workflow compatible with multiplex SNP genotyping?

Evaluations have reported concordant genotype calls in both singleplex and multiplex assay formats when crude lysates were prepared using verified workflows.

4. Does eliminating purification reduce workflow complexity? Technical evaluations indicate that crude lysate preparation using DNA Extract All Reagents may reduce processing steps, reagent use, and hands-on time compared to traditional purification workflows.


Streamline Your SNP Genotyping Workflow

If your laboratory is running targeted SNP genotyping panels, evaluate whether direct-from-lysate qPCR using DNA Extract All Reagents could simplify your workflow.

By reducing purification steps and reducing handling complexity, this approach may support more efficient SNP genotyping workflows in research settings.

Explore the DNA Extract All Reagents Kit


References

  1. Locke JM et al. Accurate and cost-effective generation of a genetic risk score direct from blood lysates. Journal of Translational Medicine. 2024.
  2. Thermo Fisher Scientific. Fast, simple SNP genotyping with multiplex qPCR. Technical note. 2026.

For Research Use Only. Not for use in diagnostic procedures.

© 2026 Thermo Fisher Scientific Inc. All rights reserved. All trademarks are the property of Thermo Fisher Scientific and its subsidiaries unless otherwise specified. TaqMan is a registered trademark of Roche Molecular Systems, Inc., used under permission and license.

Written by:

Emily Payne, PhD

Global Market Development Manager, Thermo Fisher Scientific

Emily Payne, PhD, is a Global Market Development Manager for qPCR reagents at Thermo Fisher Scientific with nearly a decade of experience in qPCR technologies. She develops scientific content in collaboration with cross-functional experts to support research and clinical applications.

Read more Payne, Emily

Leave a Reply

Your email address will not be published. Required fields are marked *